HCTI
Healthcare Triangle, Inc.
Next earnings ≈ Aug 13, 2026 · est. from filing cadence
$2.04
▲ +6.25%$2.04▼ -99.41%
over 1Y
L $1.90EODHDH $1,030.86
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.3%
1W+6.3%
1M-15.7%
3M-24.4%
YTD-94.4%
1Y-99.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Revenue grew 18.8% YoY; but unprofitable (net margin -68.2%).
Revenue (FY2025) $13.9M · FY2025
Healthcare Triangle, Inc. shows $13.9M in FY2025 revenue (+18.8% YoY), a -68.2% net margin, and -95.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $35.3M | $45.9M | $33.2M | $11.7M | $13.9M |
| Gross profit | — | — | $1.07B | $1.07B | $1.24B |
| Operating income | -$5.36M | -$10.4M | -$7.70M | -$4.75M | -$9.79M |
| Net income | -$5.95M | -$9.61M | -$8.69M | -$5.97M | -$9.48M |
| Diluted EPS | -$0.20 | -$2.63 | -$2.08 | -$16,909.30 | -$152.30 |
| Net margin | -16.9% | -20.9% | -26.2% | -51.0% | -68.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$7.13M
EV / EBITDA—
EV / Sales0.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-236.1%
FCF yield-411.8%
Quality & risk
ROIC (est.)-37.4%
Free cash flow-$16.5M
Total debt$10.7M
Net cash-$3.11M
Altman Z-Score-3.10 distress
Piotroski F-Score3/8
Capital returns
Buyback yield3.5%
Dividend yield (est.)—
Shareholder yield3.5%
Shares Δ YoY-95.6%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-04-16). Worth a closer look.
Recent filings
all on EDGAR ↗DEF 14APeriod ending 2026-07-172026-06-26open ↗8-KPeriod ending 2026-06-242026-06-26open ↗PRE 14APeriod ending 2026-06-162026-06-16open ↗DFiling2026-06-16open ↗8-KPeriod ending 2026-06-122026-06-15open ↗10-QPeriod ending 2026-03-312026-05-14open ↗10-K/APeriod ending 2025-12-312026-04-16open ↗10-KPeriod ending 2025-12-312026-04-15open ↗8-KPeriod ending 2026-04-072026-04-10open ↗8-K/APeriod ending 2026-01-222026-04-07open ↗NT 10-KPeriod ending 2025-12-312026-03-31open ↗424B5Filing2026-03-31open ↗
Frequently asked
- Is Healthcare Triangle, Inc. (HCTI) a buy?
- HCTI currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 18.8% YoY; but unprofitable (net margin -68.2%).
- What is Healthcare Triangle, Inc.'s quality score?
- HCTI scores 54.05882352941176/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001839285, latest 10-Q filed 2026-05-14) · EODHD · as of 6/22/2026, 9:47:25 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.